Fabtech Technologies Ltd

Fabtech Technologies Ltd has announced that its Board of Directors will convene on October 28, 2026, to consider and approve the un-audited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2026. The company previously informed about the closure of the trading window for its shares on September 26, 2026.

Fabtech Technologies Limited has executed a Settlement Agreement on September 29, 2026, to finalize the sale of its remaining shareholding in TSA Process Equipments Private Limited to Thermax Limited. This agreement amends certain terms related to the consideration for the second and final tranche of the transaction. The first tranche, where Thermax acquired 51% of TSA's share capital, was completed in April 2024. The second tranche involves the sale of 2,23,440 equity shares. The settlement agreement aims to facilitate the completion of this final tranche under revised terms, without altering the core objective of divesting the remaining stake. The transaction is expected to be completed by October 05, 2026, with a consideration of ₹13,98,60,000/-. TSA Process Equipments contributed NIL to Fabtech's turnover, revenue, income, and net worth in the last financial year. Thermax Limited is not a related party to Fabtech.

Fabtech Technologies Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in accordance with SEBI regulations and the company's internal codes of conduct. The window will remain shut from October 1, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter and half-year ending September 30, 2026. The specific date for the Board Meeting to consider these results will be communicated later.

Fabtech Technologies Ltd announced its Board of Directors has granted in-principle approval for the incorporation of a wholly owned step-down subsidiary in the Arab Republic of Egypt. This new entity will be established through Fabtech Technologies LLC, UAE, which is itself a wholly owned subsidiary of Fabtech Technologies Ltd. The subsidiary will focus on Turnkey Pharma Projects, including HVAC, MEP, CRP, CRE, machinery, and related activities. The incorporation is subject to regulatory approvals in Egypt and from the UAE Embassy. The equity will be subscribed in cash by Fabtech Technologies LLC at face value, resulting in Fabtech Technologies Ltd holding 100% indirectly.

Fabtech Technologies Ltd has secured a INR 21 crore turnkey design-and-build project in a CIS country, marking its entry into this new international market. The project involves developing critical internal infrastructure for an advanced medical-device manufacturing facility. Fabtech's scope includes integrated engineering, design, cleanroom systems, HVAC, and more. A key feature is the climate-responsive engineering to handle severe seasonal temperature variations. This expansion strengthens Fabtech's global execution footprint and its position as a single-point partner for complex manufacturing infrastructure. The project is targeted for handover within approximately 12 months.

Fabtech Technologies Limited, through its step-down subsidiary FTS Cleanrooms Systems LLC in the UAE, has successfully completed a 14,000 sqm turnkey facility for Himalaya Wellness Company in Dubai. The facility is designed to support pharmaceutical and cosmetic manufacturing operations and was delivered in less than a year, utilizing an integrated approach with a retained project team for continuity. This project highlights Fabtech's engineering capabilities, project execution discipline, and its strategy for international expansion in the healthcare and life sciences sectors. The completion reinforces Fabtech's ability to deliver complex, end-to-end engineering solutions for global healthcare brands.

Fabtech Technologies Ltd announced the reappointment of two directors, Mr. Amjad Adam Arbani and Mr. Naushad Alimohmed Panjwani, following approval at the 8th Annual General Meeting held on August 24, 2026. Mr. Arbani retires by rotation and sought re-appointment, while Mr. Panjwani has been re-appointed as a Non-Executive Independent Director for a second five-year term. Both directors are confirmed to be eligible and not debarred from their positions, and they are not related to any other directors. Detailed profiles are available on the company's website and in the Annual Report.

Fabtech Technologies Limited, through its UAE-based subsidiary FTS Cleanrooms Systems LLC, has won a turnkey project worth AED 9.92 million (approximately ₹24.6 crore) for Aroma King, a flavour manufacturing company in the UAE. The six-month fast-track project involves delivering critical internal infrastructure, including modular controlled environments, cold rooms, specialized flooring, HVAC, and electrical works. This project expands Fabtech's capabilities into high-specification food and flavour manufacturing, reinforcing its role as a regional execution platform and advancing its vision of becoming a global critical infrastructure provider.

Fabtech Technologies Ltd has dispatched letters to members without registered email addresses, providing web links to access the Annual Report for FY 2025-26 and the Notice of the 8th Annual General Meeting (AGM). The AGM is scheduled for August 24, 2026, at 2:00 PM IST via Video Conference/Other Audio Video Means. Electronic copies of the AGM notice and Annual Report are being sent to members with registered email addresses. Key dates for e-voting are August 17-23, 2026, with August 17, 2026, also being the record date for dividend. The dividend payment will be within 30 days of the AGM. Shareholders are urged to update their contact and bank details.

Fabtech Technologies Ltd has announced its 8th Annual General Meeting (AGM) will be held on Monday, August 24, 2026, at 2:00 p.m. IST via Video Conferencing. The company is submitting its Annual Report and AGM Notice for FY 2025-26, which is available electronically and on their website. A cut-off date of Monday, August 17, 2026, has been set for determining shareholders eligible to vote electronically and attend the AGM. This same date is also the record date for the final dividend, subject to shareholder approval at the AGM. The report highlights the company's expertise in turnkey solutions for pharmaceutical, biotech, and healthcare facilities, boasting three decades of experience and an order book of ₹900 Crore as of March 31, 2026.